Prophylactic cranial irradiation as a component of intensified initial treatment of locally advanced non-small cell lung cancer

Lung Cancer

Volumn 42, Issue 2 SUPPL., 2003, Pages 53-56

  Stuschke, M ^a   Pottgen C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Brain metastasis; Non small cell lung cancer; Prophylactic cranial irradiation

Indexed keywords

STEROID;

BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HUMAN; LUNG NON SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROPHYLACTIC CRANIAL IRRADIATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSURGERY; TREATMENT FAILURE;

EID: 18544396579     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00305-2     Document Type: Conference Paper

References (34)

1. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J. Clin. Oncol. 13:1995;1880-1892.
2. Eberhardt W., Wilke H., Stamatis G., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J. Clin. Oncol. 16:1998;622-634.
3. Feld R., Rubinstein L.V., Weisenberger T.H. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J. Clin. Oncol. 2:1984;1352-1358.
4. Figlin R.A., Piantadosi S., Feld R. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small cell lung cancer. New Engl. J. Med. 318:1988;1300-1305.
5. Komaki R., Scott C.B., Sause W.T., et al. Induction cisplatin/ vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Int. J. Radiat. Oncol. Biol. Phys. 3:1997;537-544.
6. Komaki R., Scott C.B., Byhardt R., et al. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four Radiation Therapy Oncology Group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC). Int. J. Radiat. Oncol. Biol. Phys. 42:1998;263-267.
7. Rusch V.W., Griffin B.R., Livingston R.B. The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group study. J. Thorac. Cardiovasc. Surg. 98:1989;535-539.
8. Kumar P., Herndon J., Langer M., et al. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): analysis of CALGB protocol 8935. Cancer. 77:1996;2393-2399.
9. Law A., Karp D.D., Dipetrillo T., Daly B.T. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma. Cancer. 92:2001;160-164.
10. Stuschke M., Eberhardt W., Pöttgen C., et al. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J. Clin. Oncol. 17:1999;2700-2709.
11. Robnett T.J., Machty M., Stevenson J.P., Algazy K.M., Hahn S.M. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J. Clin. Oncol. 19:2001;1344-1349.
12. Andre F., Grunenwald D., Pujol J.L., et al. Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy. Cancer. 91:2001;2394-2400.
13. Russell A.H., Pajak T.E., Selim H.M., et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;637-643.
14. Jacobs R.H., Awan A., Bitran J.C., et al. Prophylactic cranial irradiation in adenocarcinoma of the lung: a possible role. Cancer. 59:1987;2016-2019.
15. Cox J.D., Stanley K., Petrovich Z., Paig C., Yesner R. Cranial irradiation in cancer of the lung of all cell types. J. Am. Med. Assoc. 245:1981;469-472.
16. Umsawasdi T., Valdivieso M., Chen T.T., et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J. Neurooncol. 2:1984;253-259.
17. Miller T.P., Crowley J.J., Mira J., et al. A randomised trial of chemotherapy and radiotherapy for stage III non-small cell lung cancer. Cancer Therap. 1:1998;229-236.
18. Cull A., Gregor A., Hopwood P., et al. Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur. J. Cancer. 30A:(8):1994;1067-1074.
19. Johnson B.E., Becker B., Goff W.B., et al. Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer. J. Clin. Oncol. 3:1985;1659-1667.
20. Johnson B.E., Patronas N., Hayes W., et al. Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6- to 13-year survivors. J. Clin. Oncol. 8:1990;48-56.
21. van Oosterhout A.G.M., van de Pol M., ten Velde G.P.M., Twijnstra A. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Cancer. 77:1996;1434-1441.
22. Arriagada R., Le Chevalier T., Borie F. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J. Natl. Cancer Inst. 87:1995;183-190.
23. Gregor A., Cull A., Stephens R.J., et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. UKCCR and the EORTC. Eur. J. Cancer. 33:1997;1752-1758.
24. Suwinski R., See S.P., Withers R. Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;797-806.
25. Kurtz J.M., Gelber R., Brady L.W., Carella R.J., Cooper J.S. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 7:1981;891-895.
26. Li B., Yu J., Suntharalingam M., et al. Comparison of three treatment options for single brain metastasis from lung cancer. Int. J. Cancer. 90:2000;37-45.
27. Schiff D. Single Brain Metastasis. Curr. Treat. Options Neurol. 3:2001;89-99.
28. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. J. Am. Med. Assoc. 280:1998;1485-1489.
29. Sperduto P.W., Scott C., Andrews D., et al. Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: report of Radiation Oncology Group phase III study 95-08 (Abstract). Int. J. Radiat. Oncol. Biol. Phys. 54 (Suppl):2002;3.
30. Williams J., Enger C., Wharam M., Tsai D., Brem H. Stereotactic radiosurgery for brain metastases: comparison of lung carcinoma vs. non-lung tumors. J. Neurooncol. 37:1998;79-85.
31. Burt M., Wronski M., Arbit E., Galicich J.H. Resection of brain metastases from non-small cell lung carcinoma. Results of therapy. J. Thoracic. Cardiovasc. Surg. 103:1992;399-410.
32. Nussbaum E.S., Djalilian H.R., Cho K.H., Hall W.A. Brain metastases: histology, multiplicity, surgery, and survival. Cancer. 78:1996;1781-1788.
33. Schellinger P.D., Meinck H.M., Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J. Neurooncol. 44:1999;275-281.
34. Cox J.D., Scott C.B., Byhardt R.W. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of the lung: analysis of the radiation therapy oncology group trials. Int. J. Radiat. Oncol. Biol. Phys. 43:1999;505-509.